Open AccessTYPE 2 DIABETICS
Author(s) -
Mohammad Mohsin Rana,
Muhammad Badar Bashir,
Muhammad Saeed Akhtar,
Abaid-Ur Rehman
Publication year - 2006
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2006.13.03.4997
Subject(s) - medicine , metabolic syndrome , diabetes mellitus , obesity , hyperinsulinemia , insulin resistance , type 2 diabetes mellitus , blood pressure , type 2 diabetes , abdominal obesity , risk factor , disease , endocrinology
The combination of hypertension, dyslipedemia, centralobesity with insulin resistance or hyperinsulinemia or glucose intolerance has been termed the "Metabolic Syndrome."This syndrome is a powerful determinant for cardiovascular disease. Presence of one risk factor mandates search forother factors. Hypertension and obesity and smoking are assessed clinically while Hyperglycemia and dyslipedemiaare detected by lab screening. Objective: To detect the other component of metabolic syndrome in type 2 diabetics.Design of study: Observational study. Setting: At Al-Shifa Metabolic Center, Faisalabad. Study Period: FromJanuary 2005 to June 2006 Materials And Methods: All patients with type2 diabetes mellitus were assessed forhypertension, central obesity and fasting serum cholesterol to define the different components of the MetabolicSyndrome. on diabetics presenting for routine consultancy. Results. A total of 8300 labeled type2 diabetics wereenrolled. Random blood sugar, blood pressure and central obesity by waist hip ratio were assessed and appointmentwas given for complimentary screening of fasting serum cholesterol and triglyceroid level. Only 2656 presented forscreening of lipids and only this group was evaluated further. 92% of patients were between 30-70 years of age. 8%were above the age of 70. There were 39% males and 61% females, 39% of diabetics had hypertension, 60% werecentrally obese, 69% had fasting serum cholesterol level above 150 mg/dL and 49% had fasting serum triglyceride levelabove 150mg/dl. Conclusion. Diabetes Mellitus, obesity, especially the central type, hypertension and dyslipedemiaare metabolically linked together. All of these are clustered together quiet frequently. These are well-established riskfactors for coronary heart disease, the major cause of mortality. Treating hyperglycemia alone in diabetics does notprotect coronaries. All of the risk factors shall be defined and treated together in every patient at risk of CHD. Treatingobesity is beneficial in glycemic, lipemic and hypertension control.